Want to join the conversation?
$ATI 2Q15 PR: Total sales for the quarter were $1,022MM compared to $1,119MM in 2Q14. Sales declined 9% compared to the first quarter 2015. Net loss for the quarter was $16.4MM compared to net loss of $4MM in 2Q15, and net loss from continuing operations attributable to ATI of $3.8MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.